Notable Labs, Ltd.

As of June 30, 2024, Notable Labs, Ltd. carries a market capitalization of 6.07M, placing it among publicly traded companies globally. Its enterprise value stands at 3.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Notable Labs, Ltd.'s next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2024, Notable Labs, Ltd. has 9.66M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, Notable Labs, Ltd. maintains a current ratio of 2.77, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2024. The company generates approximately 285.71 in revenue per employee across its workforce of 7.00, a quick read on workforce productivity versus industry peers.

As of the close on October 19, 2026, Notable Labs, Ltd.'s stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.29.

These figures cover the twelve months ended June 30, 2024.

As of June 30, 2024, Notable Labs, Ltd. holds 4.09M in cash and equivalents against 1.80M in total debt, resulting in a net debt position of -4.09M. Total book value stands at 7.19M, with working capital of 4.47M providing operational flexibility.

These figures cover the twelve months ended June 30, 2024. After subtracting -8,000.00 in capital expenditures, free cash flow totaled -3.72M - equivalent to -0.39 per share.

Over the twelve months ended June 30, 2024, Notable Labs, Ltd. posted a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -269,000.00 and net profit margin of -260,950.00 provide insight into operational efficiency.

Notable Labs, Ltd.'s most recent stock split took place on October 17, 2023 with a 35:1 split ratio.